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S U M M A R Y
Background: The epidemiology of meticillin-resistant Staphylococcus aureus (MRSA)
infections, using bacteraemia as a marker, shows a striking geographical pattern in Europe.
The prevalence of MRSA is low in Northern European countries, increases into central Europe
and reaches its highest levels in the Mediterranean region. This has been attributed to
varying levels of implementation of infection control and antibiotic stewardship (ICAS)
programmes, but reasons for this variation have not been clearly established.
Aim: To investigate the possible impact of national cultural dimensions on the epidemi-
ology of MRSA in Europe.
Methods: Median proportions of MRSA bacteraemia were sourced for countries partici-
pating in the EARS-Net surveillance network in 2010, and correlated with the national
cultural dimension scores of Hofstede et al.
Findings: Significant associations were identified between MRSA proportions and the
cultural constructs of uncertainty avoidance (UAI), masculinity (MAS) and power distance.
Multiple regression models found significant associations for UAI, MAS and short-term
orientation (R2 adjusted ¼ 0.475; P < 0.001). The model was found to be predictive of
MRSA trends identified in several European countries between 2006 and 2010.
Conclusion: Implementation of ICAS programmes often requires behavioural change.
Cultural dimensions appear to be key factors affecting perceptions and values among
healthcare workers, which in turn are critical for compliance and uptake. Customizing
ICAS initiatives to reflect the local cultural background may improve their chances of
success.
 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Introduction
Bloodstream infections (BSI) caused by meticillin-resistant
Staphylococcus aureus (MRSA) constitute a major challenge
to healthcare institutions, particularly in terms of associated
mortality.1 A significant reduction in MRSA BSI has been shown
to be achievable through effective infection control and anti-
biotic stewardship (ICAS) interventions within hospitals.2 As
a result, mandatory surveillance of MRSA BSI coupled with
reduction targets has been introduced in some countries.3
Improvement in MRSA BSI incidence is used to monitor the
effectiveness of ICAS programmes.4 National MRSA proportions
have been shown to correlate well with incidence, and have
been used to calculate overall MRSA incidence at country
level.5 For more than a decade, comparable surveillance of
MRSA proportions in blood cultures has been ongoing in the
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majority of European countries through the European Antimi-
crobial Resistance Surveillance System (EARSS). The results
from the EARSS network, now EARS-Net, show a consistent
geographical pattern. The prevalence of MRSA is low (at times
practically absent) in almost all Northern European countries,
increases into central Europe and reaches its highest levels in
the Mediterranean region.6
Similar geographical variation exists in ambulatory care
antibiotic consumption within the same region.7 This has been
ascribed to be linked to national cultural differences.8,9 Hof-
stede’s model of cultural dimensions is one of the most
accepted approaches for analysis of cultural differences
between countries, with more than 800 citations in peer-
reviewed journals. It defines culture as the collective
programming of the mind that distinguishes the members of
one group or category of people from another. Hofstede
formulated a model which proposes that national cultures vary
along consistent, fundamental dimensions which can be grou-
ped and scored as specific constructs: power distance (PDI),
individualism (IDV), masculinity (MAS) and uncertainty avoid-
ance (UAI). Later, in collaboration with other colleagues, he
identified two more dimensions following the analysis of
diverse databanks: long-term vs short-term orientation (LTO)
and indulgence vs restraint (IVR) (Box 1).10
Methods
The MRSA proportions reported in the 2010 annual epide-
miological report of EARS-Net were used in this study.11 EARS-
Net calculated the proportion for each hospital by using the
number of S. aureus blood culture isolates that showed
oxacillin resistance as the numerator, and the total number of
S. aureus bacteraemias as the denominator, both on a first per
patient basis. The median national proportion was established
for each participating country. Hofstede scores for PDI, IDV,
MAS, UAI, LTO and IVR were identified for the countries in the
EARS-Net surveillance network. These are freely available for
research purposes from Hofstede’s website and publications.12
EARS-Net countries for which Hofstede scores were not avail-
able were excluded from further analysis. Pearson correlation
was performed between the median hospital MRSA proportion
for each country and the corresponding national Hofstede
scores. Multiple regression models were built through the
forward technique using each country’s median MRSA propor-
tion as the dependant variable. Adequacy of the models was
confirmed through analysis of variance, Durbin-Watson test for
autocorrelation and colinearity diagnostics. Analyses were
performed using Statistical Package for the Social Sciences
Version 20 (SPSS Inc., Chicago, IL, USA) assuming a 0.05 level of
significance.
EARS-Net countries with a minimum of 10 participating
hospitals that reported MRSA median proportions of 15% or
more during 2010 were identified. MRSA proportions reported
by every hospital in each of these countries were also retrieved
for the years 2006e2009, again from the respective EARS-Net
annual reports. Generalized linear regression models were
used to identify significant changes in the MRSA proportions
over the five-year period for each country. Where the distri-
bution of proportions reported by hospitals in a country was
symmetrical, a normal distribution was assumed; where the
distribution of proportions was right skewed, a Gamma distri-
bution was assumed.
Results
MRSA proportions for 2010 were available for 26 European
countries participating in EARS-Net. Median hospital propor-
tions varied from 0% in Denmark, Estonia, the Netherlands,
Norway and Sweden to 55.6% in Malta. Hofstede scores were
available for all EARS-Net countries except Cyprus and Iceland;
these two countries were therefore excluded from further
analysis (Table I). On univariate analysis, MRSA proportions
were found to be significantly associated with UAI, MAS and PDI
(Table II). On multiple regression analysis, MRSA proportions
were found to be significantly associated with UAI, MAS and
LTO. The model explained 47.5% of the variation in national
MRSA proportions within Europe (R2 adjusted ¼ 0.475,
P < 0.001) (Table II).
In 2010, 11 countries reported MRSA proportions of 15% or
more from more than 10 hospitals (Figure 1). Following
regression analysis, most of these countries did not show any
significant trends between 2006 and 2010. However, significant
year-on-year reductions in MRSA were recorded in France [beta
coefficient (B) ¼ 0.0107, P ¼ 0.001], Ireland (B ¼ 0.0358,
P < 0.001) and the UK (B ¼ 0.0238, P < 0.001).
Discussion
A number of studies have attempted to elucidate reasons for
the variation in MRSA rates in Europe. Hansen et al. concluded
that countries with decreasing MRSA proportions showed
stricter ICAS implementation within hospitals.13 The ARPAC
Box 1
Hofstede definitions for the six cultural dimensions (adapted from http://www.geerthofstede.nl).
Power distance (PDI) relates to the extent to which the less powerful members of organizations and institutions accept and expect
that power is distributed unequally. It suggests that a society’s level of inequality is endorsed by the followers as much as by the
leaders.
Uncertainty avoidance (UAI) indicates the extent to which a society tolerates uncertainty and ambiguity, and shows how
comfortable its members feel in unstructured situations which are novel, unknown, surprising or different from usual.
Individualism (IND) is the degree to which individuals are integrated into tight groups (collectivist) or loose groups (individualist).
Masculinity (MAS) refers to the distribution of roles between the genders. In masculine cultures, ego needs, assertiveness and
success are emphasized. In feminine cultures, caring for the weak and quality of life are more important.
Long-term orientation (LTO) reflects long-term pragmatic attitudes vs short-term normative attitudes. Cultures scoring high on this
dimension show emphasis on future rewards, in particular saving, persistence and adapting to changing circumstances.
Indulgence (IVR) reflects societies that allow people to enjoy life and have fun vs societies where restraint is emphasized.
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study identified correlations between MRSA prevalence and
antibiotic consumption, use of alcohol hand rub and compli-
ance with isolation policies.14 Nevertheless, these studies did
not explain why these ICAS measures have not been imple-
mented equally effectively across all European countries. This
is especially relevant considering that the European Union has
made a concerted effort to reduce healthcare-associated
infections (HAI) caused by resistant organisms such as MRSA
over the past decade.15 During this time, numerous change
tools have become available for achieving better hand hygiene
compliance,16 antibiotic stewardship,17 and prevention of
device-associated bacteraemia.18 Moreover, there is clear
evidence of the cost-effectiveness of ICAS, both in financial
terms and in terms of patient safety.19 However, despite the
potential benefits to be gained from HAI reduction, few
European countries have achieved significant improvement in
MRSA BSI.
Nicol et al. proposed a model for healthcare worker (HCW)
compliance with ICAS practices such as hand hygiene, based on
the theory of planned behaviour.20 They suggested that satis-
factory behaviour must be preceded by predisposition. The key
to success is risk appraisal by HCWs, who need to genuinely
accept and comprehend the risks and impact of HAIs before
performing the necessary ICAS interventions to mitigate them.
It follows that one of the most important elements that drives
behaviour in humans e values and perceptions e could have
a major impact on ICAS-related practice and outcomes. The
predictive model identified UAI as the strongest cultural
dimension related to the prevalence of MRSA. Hofstede
emphasized that uncertainty avoidance is not the same as risk
avoidance. Indeed, people in high UAI countries are reported to
be very tolerant of familiar risk and prone to management by
crisis. HCWs in these countries are therefore more likely to
underestimate HAIs which they encounter on a regular daily
basis, and tolerate risk activities that predispose to them. It is
more challenging to instill ownership of HAI prevention where
the problem is regarded as a hospital-wide issue, rather than
one in which the individual HCW can make a direct impact.
There is a greater likelihood of non-compliance of key ICAS
interventions, such as hand hygiene, which require extra effort
or time, and may be perceived as increasing work-related
pressures. Indeed, the avoidance of stress is a major element
of UAI cultures. The authors believe that it is not coincidental
that the five European countries with the highest MRSA
proportions all possess very high UAI scores. However, UAI was
not the only component of the predictive model, which also
incorporated MAS and LTO. MAS cultures are highly assertive,
decisive and driven by precise targets. As a result, they tend to
be less effective than more feminine cultures in activities that
require a caring attitude. Furthermore, it is logical to extrap-
olate that administrators in cultures that score low in LTO
would also be less amenable to support and fund ICAS pro-
grammes which may need considerable investment over
several years before showing reductions in infection rates.
The regression analysis showed that the greatest reduction
in MRSA proportions in Europe over the past five years was
achieved in the UK and Ireland. This confirms previous
Table II
Individual correlation and multiple regression analysis between
national Hofstede cultural dimension scores and 2010 meticillin-
resistant Staphylococcus aureus (MRSA) proportions reported by
countries participating in EARS-Net
Cultural dimension Correlation coefficient P
Univariate analysis
PDI 0.515 0.007
UAI 0.603 0.001
MAS 0.461 0.018
IND 0.314 0.119
LTO 0.237 0.243
IVR 0.078 0.703
Multiple regression
Constant 1.551
UAI 0.365 0.002
MAS 0.214 0.05
LTO 0.281 0.05
Adjusted R2 0.475
F ratio 8.53
P 0.001
PDI, power distance; UAI, uncertainty avoidance; IND, individualism;
MAS, masculinity; LTO, long-term vs short-term orientation; IVR,
indulgence vs restraint.
Table I
Median meticillin-resistant Staphylococcus aureus (MRSA) propor-
tions from hospitals in 26 European countries as reported by the
EARS-Net network for 2010 together with the Hofstede dimensional
scores for the respective countries
Country EARS-Net results Hofstede country scores
Hospitals Median
MRSA (%)
PDI IDV MAS UAI LTO IVR
Austria 107 3.6 11 55 79 70 60 63
Belgium 36 19.8 65 75 54 94 82 57
Bulgaria 18 17.8 70 30 40 85 69 16
Czech Republic 66 13.3 57 58 57 74 70 29
Denmark 51 0 18 74 16 23 35 70
Estonia 19 0 40 60 30 60 82 16
Finland 20 0.9 33 63 26 59 38 57
France 57 21.9 68 71 43 86 63 48
Germany 128 19.1 35 67 66 65 83 40
Greece 45 39.8 60 35 57 112 45 50
Hungary 44 25.3 46 80 88 82 58 31
Ireland 50 23.8 28 70 68 35 24 65
Italy 44 36.8 50 76 70 75 61 30
Latvia 11 4.5 44 70 9 63 69 13
Lithuania 16 5.3 42 60 19 65 82 16
Luxembourg 6 15 40 60 50 70 64 56
Malta 3 55.6 56 59 47 96 47 66
Netherlands 56 0 38 80 14 53 67 68
Norway 39 0 31 69 8 50 35 55
Poland 49 11.1 68 60 64 93 38 29
Portugal 23 49.1 63 27 31 104 28 33
Romania 6 37.1 90 30 42 90 52 20
Slovenia 15 10 71 27 19 88 49 48
Spain 41 24.2 57 51 42 86 48 44
Sweden 59 0 31 71 5 29 53 78
UK 93 27.3 35 89 66 35 51 69
PDI, power distance; UAI, uncertainty avoidance; IND, individualism;
MAS, masculinity; LTO, long-term vs short-term orientation; IVR,
indulgence vs restraint.
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publications from these countries, highlighting the rapidity and
extent by which MRSA levels have decreased.21 Improvement
was achieved in both intensive care settings and general wards.
Both countries scored low for UAI but high for MAS. Targets are
extremely effective in such a cultural mindset, which explains
the rapid change achieved when MRSA and Clostridium difficile
reduction became genuinely important national and institu-
tional goals.3 However, a significant reduction in MRSA has also
been evident in France. This might appear incongruent as
France shows substantially higher UAI scores than the UK and
Ireland, as well as lower MAS scores, especially in professional
socio-economic classes. However, the improvement trends in
this country show somewhat different characteristics to those
in the British Isles, not least in the extent and speed of reduc-
tion achieved. Jarlier et al. reported a concerted campaign in
France, starting in 1993, based primarily on guidelines, barrier
precautions and isolation.22 Improvement over subsequent
years was modest, but increased following a central ministerial
initiative in 2001 that implemented five reportable national
quality indicators to benchmark hospital performance.23
Improvement was sharpest in intensive care units and less
rapid in general wards, especially in medical departments
where the reduction before 2001 was negligible.22 Malta and
Italy have also reported significant improvement in MRSA inci-
dence in intensive care thatwas not evident in general wards. In
high UAI backgrounds, change may be more difficult to imple-
ment in the heterogeneous environments found in general
wards as opposed to intensive care environments, where nurses
are normally assigned to individual patients and may feel
a greater personal ownership for the outcome.
The data used for this study were derived from the exten-
sive EARS-Net network and its standardized surveillance
protocol covering more than 1000 European hospitals in 26
countries. Calculating median MRSA proportions based on
individual participating hospitals, rather than the overall
country mean, reduces the risk of possible bias from larger
hospitals reporting inordinate numbers of isolates, especially in
smaller countries. However, this study has a number of limi-
tations. First, the extent of national coverage by EARS-Net
laboratories is far from uniform across Europe, being quite
low in some Eastern European countries. The EARS-Net
protocol does not differentiate between healthcare or
community acquisition. Community-acquired MRSA is becoming
increasingly important in the European landscape.24 Second,
some publications have attributed reduction within individual
hospitals to MRSA strain variation over time.25 Nevertheless,
the UK and French experiences clearly demonstrate the utility
of MRSA bacteraemia as a marker for the effectiveness of ho-
spital ICAS implementation. Third, Hofstede scores originated
from studies in the general population, rather than specifically
among healthcare professionals and administrators.
The model used in this study was able to account for almost
half of the variance in European MRSA proportions solely on the
basis of national cultural dimensions. Provided that the iden-
tified association is causal in nature, it introduces a novel
parameter in the aetiology of HAI. The regression model shows
concomitant variation at a remarkable level of statistical
significance. Temporal priority is also present, with national
cultural dimensions predating modern medicine by centuries.
However, causality also requires elimination of plausible
alternatives and confounders. Cultural dimensions have been
shown to be associated with inappropriate antibiotic use in
European ambulatory care.8 Antibiotic misuse in such settings
can predispose to community acquisition of MRSA and its
0
5
10
15
20
25
30
35
40
45
50
Bulgaria Germany Belgium France Ireland Spain Hungary UK Italy Greece Portugal
Country
M
R
SA
 p
ro
po
rti
on
 (%
)
2006 2007 2008 2009 2010
Figure 1. Five-year trends for EARS-Net countries reporting median meticillin-resistant Staphylococcus aureus (MRSA) proportions of 15%
or more in 2010 from at least 10 hospitals.
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introduction into hospital on admission of the patient. Never-
theless, the UK experience, where the decline in MRSA started
well before admission screening was introduced, suggests that
this is unlikely to be a major factor.21 Moreover, even if con-
founding were to be a factor, the present findings would still
indicate that some determinant of societal characteristics also
contributes to the observed variation in European MRSA rates.
Whilst potentially controversial, a causal association
between cultural characteristics and MRSA rates should not be
totally surprising since ICAS implementation is ultimately
behavioural science: the need for culture change to obtain
lasting reduction in HAI has been emphasized repeatedly.26
Culture is often regarded as a nebulous concept, but the
present study suggests that clearly defined and measurable
national traits impact heavily on patient safety and quality of
care initiatives. For ICAS programmes to be effective over the
whole range of hospitals in a country, rather than just in indi-
vidual institutions, they may need to overcome core values
that have developed over centuries (Hofstede defines them as
mental software). These differ significantly between coun-
tries. The bulk of ICAS implementation literature originates
from and has been validated in Anglo-Saxon countries, all of
which are characterized by low UAI and high MAS. It is not
surprising that they focus heavily on surveillance and audit
together with collaborative teamwork as components of
a planedoestudyeact cycle.27 However, audits are specifically
meant to identify suboptimal practice and are, by their very
nature, major generators of uncertainty. In strong UAI cultures,
they can elicit severe discomfort amongst HCWs, further
increasing the daily individual stress experienced by people in
these countries. This may increase the tendency to ignore
them. Worse, they may trigger a counter-productive antago-
nism, especially where MAS is also high. Indeed, a large cohort
of HCWs from eight Mediterranean countries felt that audit and
feedback was the least important intervention to improve hand
hygiene in their hospitals.28 High UAI cultures are also char-
acterized by respect for those with knowledge, reflected in
deference for titles and degrees. Furthermore, there is a strong
correlation between UAI and PDI among European countries,
which was evident in the zero order coefficients of the model
used in this study. In such environments, it can be a challenge
to convince administrators to adopt a no-blame approach to
audit results, achieve equitable collaboration between
different healthcare professionals (especially doctors with
nurses), or foster a genuine culture of collegial reminders such
as in instances of hand hygiene non-compliance.29 These have
been the cornerstone of many successful infection prevention
initiatives in the USA, UK and Northern Europe.30 To ensure
maximal uptake and impact, it is therefore crucial that ICAS
interventions transposed from a different background are
adapted to the local culture.
Culture is, of course, not the only factor affecting the
epidemiology of HAI. However, the association identified in the
present study offers a new insight into our understanding of
infection prevention. It would explain the lack of improvement
in high MRSA endemic countries with conducive combinations
of cultural traits. More research is clearly required into these
preliminary findings. Studies that focus on ICAS parameters,
rather than surrogate markers, and correlate behaviour and
compliance with cultural dimensions of HCW cohorts are
needed. Better understanding of cultural influences may help
European infection control professionals achieve meaningful
behavioural change and reduce HAI in their own particular
settings.
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